IPCA Laboratories share news, announcements and annual reports
NSE: IPCALABBSE: 524494Pharmaceuticals & BiotechnologyMid Cap
Share price at the NSE close on 28 Oct 2026. Previous close ₹1,980.80.
28 Oct: open ₹1,980.00, high ₹1,988.50, low ₹1,920.10
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹48,978 Cr229th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 37.39
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.07
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.31%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 17.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,75,48945.2% delivered
IPCA Laboratories analyst meets
68 filed, newest first. Page 1 of 2.
Oct 2026
28 Oct · Analysts
Aug 2026
17 Aug · Analysts
6 Aug · Analysts
Jun 2026
May 2026
21 May · Analysts
Feb 2026
6 Feb · Analysts
Nov 2025
12 Nov · Analysts
6 Nov · Analysts
Aug 2025
5 Aug · Analysts
Jun 2025
16 Jun · Analysts
May 2025
23 May · Analysts
Feb 2025
10 Feb · Analysts
Nov 2024
8 Nov · Analysts
Aug 2024
7 Aug · Analysts
May 2024
25 May · Analysts
Feb 2024
8 Feb · Analysts
Oct 2023
31 Oct · Analysts
Aug 2023
4 Aug · Analysts
May 2023
30 May · Analysts
24 May · Analysts
Apr 2023
24 Apr · Analysts
Feb 2023
9 Feb · Analysts
Nov 2022
9 Nov · Analysts
8 Nov · Analysts
Sep 2022
19 Sep · Analysts
Aug 2022
5 Aug · Analysts
May 2022
20 May · Analysts
Feb 2022
10 Feb · Analysts
9 Feb · Analysts
Dec 2021
14 Dec · Analysts
Nov 2021
17 Nov · Analysts
10 Nov · Analysts
Sep 2021
27 Sep · Analysts
13 Sep · Analysts
Aug 2021
9 Aug · Analysts
2 Aug · Analysts
Jun 2021
7 Jun · Analysts
1 Jun · Analysts
May 2021
27 May · Analysts
Mar 2021
26 Mar · Analysts
Jan 2021
29 Jan · Analysts